NVO’s Ozempic Outshines LLY’s Mounjaro in Lowering Cardiovascular Risk
Novo NVO announced new real-world data from the COMPETE SWITCH Cardiovascular (CV) study comparing treatment strategies in adults…
America’s FDA just approved the first GLP-1 weight-loss pill. Here’s what to know
Eli Lilly has sought FDA approval for its own weight-loss pill as the two pharmaceutical giants continue their…
Wegovy pill could deliver as much weight loss as the shot, trial shows
Eli Lilly and Novo Nordisk are vying for supremacy in the weight-loss market they dominate as they both…